Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Stelios I, Tsintzos"'
Autor:
Vasileios F. Panoulas, Javier Escaned, Jonathan M. Hill, Erin Barker, Karin Butler, Ali Almedhychy, Stelios I. Tsintzos, William W. O’Neill
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Revascularization completeness after percutaneous coronary intervention (PCI) is associated with improved long-term outcomes. Mechanical circulatory support [intra-aortic balloon pump (IABP) or Impella] is used during high-risk PCI (HR-PCI) to enhanc
Externí odkaz:
https://doaj.org/article/2a37d61ea94147f1adf4ac14940240a5
Autor:
Stephan Schueler, Scott C. Silvestry, William G. Cotts, Mark S. Slaughter, Wayne C. Levy, Richard K. Cheng, Jennifer A. Beckman, Jonas Villinger, Eleni Ismyrloglou, Stelios I. Tsintzos, Claudius Mahr
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 3049-3057 (2021)
Abstract Aims Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac
Externí odkaz:
https://doaj.org/article/ca3d8120b593478db3d145f7b0a24991
Autor:
Klaus K. Witte, Georgios Tsivgoulis, Matthew R. Reynolds, Stelios I. Tsintzos, Simon Eggington, Eleni Ismyrloglou, Julie Lyon, Marianne Huynh, Marta Egea, Bonnie de Brouwer, Paul D. Ziegler, Noreli Franco, Rashmi Joglekar, Sarah C. Rosemas, Shufeng Liu, Vincent Thijs
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Objective Prevention of recurrent stroke in patients with embolic stroke of undetermined source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral anticoagulants (DOACs) has prompted exploration of prophyla
Externí odkaz:
https://doaj.org/article/d665ee0ebc50438b9ac746f26793d002
Autor:
Brad S Sutton, Sarah L Bermingham, Sarah C Rosemas, Stelios I Tsintzos, Ying Xia, Matthew R Reynolds
Publikováno v:
Open Heart, Vol 8, Iss 1 (2021)
Introduction Early use of insertable cardiac monitor (ICM) is recommended for patients with unexplained syncope following initial clinical workup, due to its superior ability to establish symptom-rhythm correlation compared with conventional testing
Externí odkaz:
https://doaj.org/article/cf41bfac14884527b23be52f85a71d73
Autor:
Christopher D. Anderson, Joshua O. Ikuemonisan, James B. Young, John Rickard, Xiaoxiao Lu, Stelios I Tsintzos, Dedra H. Fagan, Eugene S. Chung, Michael R. Gold, Cecilia Linde, William T. Abraham
Publikováno v:
Heart Rhythm. 19:595-603
Cardiac resynchronization therapy (CRT) reduces mortality and improves outcomes in appropriately selected patients with heart failure (HF); however, response may vary.We sought to correlate 6-month CRT response assessed by clinical composite score (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695c92238be85344506151cd410c66a9
https://doi.org/10.1016/j.hrthm.2021.11.030
https://doi.org/10.1016/j.hrthm.2021.11.030
Autor:
K K Witte, David Lanctin, Stelios I Tsintzos, L. Sawyer, Claudia Rinciog, Scott E. Kasner, Matthew R. Reynolds, Sarah C Rosemas, Mitchell Elkind, Paul D. Ziegler, Frank Jones
Publikováno v:
BMC Cardiovascular Disorders. 23
Background Insertable cardiac monitors (ICMs) are a clinically effective means of detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin K oral anticoagulants (NOACs). Their cost-effectiveness from a US cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278aaf4f822e38588d583f5702e2055a
https://doi.org/10.1186/s12872-023-03073-6
https://doi.org/10.1186/s12872-023-03073-6
Autor:
Stelios I Tsintzos, Claudius Mahr, Mark S. Slaughter, William Cotts, Richard Cheng, Eleni Ismyrloglou, Jennifer A. Beckman, Wayne C. Levy, Scott C. Silvestry, Jonas Villinger, Stephan Schueler
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 4, Pp 3049-3057 (2021)
ESC Heart Failure, Vol 8, Iss 4, Pp 3049-3057 (2021)
Aims Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transpla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc952f550fc51633bba25ba2a42dfd26
http://europepmc.org/articles/PMC8318455
http://europepmc.org/articles/PMC8318455
Autor:
Stelios I. Tsintzos, Jennifer A. Beckman, Anson Cheung, Wayne C. Levy, Martin Strueber, Scott C. Silvestry, Damian M May, Matthew R. Danter, Eleni Ismyrloglou, Nahush A. Mokadam, Mark S. Slaughter, Claudius Mahr, Richard Cheng, Edwin C. McGee
Publikováno v:
Asaio Journal
Supplemental Digital Content is available in the text.
This study reports the first analysis regarding cost-effectiveness of left ventricular assist device (LVAD) implantation via thoracotomy. Cost-effectiveness of LVADs implanted via the tradit
This study reports the first analysis regarding cost-effectiveness of left ventricular assist device (LVAD) implantation via thoracotomy. Cost-effectiveness of LVADs implanted via the tradit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1a11c1447327395a882b84aaaa2b99
http://europepmc.org/articles/PMC7386860
http://europepmc.org/articles/PMC7386860
Autor:
Ruth N. Klepfer, Dedra H. Fagan, Antonio Hernández-Madrid, Eugene S. Chung, Stelios I Tsintzos, Roberto Matía, Xiaoxiao Lu
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Antonio Hernández-Madrid,1 Xiaoxiao Lu,2 Stelios I Tsintzos,3 Dedra H Fagan,2 Ruth Nicholson Klepfer,2 Roberto Matía,1 Eugene S Chung41Arrhythmia Unit, Cardiology Department, Ramón y Cajal Hospital, Alcalá University, Madrid, Spain; 2Medtronic, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba25014de61d27559bdacd0ae571c793
http://europepmc.org/articles/PMC6559257
http://europepmc.org/articles/PMC6559257
Autor:
Vincent Thijs, Stelios I Tsintzos, Simon Eggington, Eleni Ismyrloglou, Georgios Tsivgoulis, Marta Egea, Rashmi Joglekar, Matthew R. Reynolds, Shufeng Liu, Noreli Franco, Sarah C Rosemas, Bonnie de Brouwer, Julie Lyon, Paul D. Ziegler, Marianne Huynh, Klaus K. Witte
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Objective Prevention of recurrent stroke in patients with embolic stroke of undetermined source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral anticoagulants (DOACs) has prompted exploration of prophylactic anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102bde6dd968e6fdbf03e911753152fe
https://doi.org/10.1186/s12872-021-01967-x
https://doi.org/10.1186/s12872-021-01967-x